Literature DB >> 16731941

The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.

Adrianus C M Boon1, Gerrie de Mutsert, Ron A M Fouchier, Albert D M E Osterhaus, Guus F Rimmelzwaan.   

Abstract

Recently it was shown that influenza A viruses can accumulate mutations in epitopes associated with escape from recognition by human virus-specific cytotoxic T lymphocytes (CTL). It is unclear what drives diversification of CTL epitopes and why certain epitopes are variable and others remain conserved. It has been shown that simian immunodeficiency virus-specific CTL that recognize their epitope with high functional avidity eliminate virus-infected cells efficiently and drive diversification of CTL epitopes. T-cell functional avidity is defined by the density of major histocompatibility complex class I peptide complexes required to activate specific CTL. We hypothesized that functional avidity of CTL contributes to epitope diversification and escape from CTL also for influenza viruses. To test this hypothesis, the functional avidity of polyclonal CTL populations specific for nine individual epitopes was determined. To this end, peripheral blood mononuclear cells from HLA-A- and -B-genotyped individuals were stimulated in vitro with influenza virus-infected cells to allow expansion of virus-specific CTL, which were used to determine the functional avidity of CTL specific for nine individual epitopes in enzyme-linked immunospot assays. We found that the functional avidity for the respective epitopes varied widely. Furthermore, the functional avidity of CTL specific for the hypervariable NP(418-426) epitope was significantly higher than that of CTL recognizing other epitopes (P < 0.01). It was speculated that the high functional avidity of NP(418-426)-specific CTL was responsible for the diversification of this influenza A virus CTL epitope.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731941      PMCID: PMC1472604          DOI: 10.1128/JVI.00009-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines.

Authors:  G F Rimmelzwaan; N Nieuwkoop; A Brandenburg; G Sutter; W E Beyer; D Maher; J Bates; A D Osterhaus
Journal:  Vaccine       Date:  2000-12-08       Impact factor: 3.641

2.  A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.

Authors:  G T Belz; W Xie; J D Altman; P C Doherty
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.

Authors:  C Sedlik; G Dadaglio; M F Saron; E Deriaud; M Rojas; S I Casal; C Leclerc
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

4.  Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.

Authors:  W Chen; L C Antón; J R Bennink; J W Yewdell
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

5.  Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Authors:  J T Voeten; T M Bestebroer; N J Nieuwkoop; R A Fouchier; A D Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Memory T cell populations in the lung airways are maintained by continual recruitment.

Authors:  Kenneth H Ely; Tres Cookenham; Alan D Roberts; David L Woodland
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

7.  Functional profile of human influenza virus-specific cytotoxic T lymphocyte activity is influenced by interleukin-2 concentration and epitope specificity.

Authors:  A C M Boon; G de Mutsert; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

8.  Perforin and Fas cytolytic pathways coordinately shape the selection and diversity of CD8+-T-cell escape variants of influenza virus.

Authors:  Graeme E Price; Lei Huang; Rong Ou; Menghua Zhang; Demetrius Moskophidis
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

9.  Full restoration of viral fitness by multiple compensatory co-mutations in the nucleoprotein of influenza A virus cytotoxic T-lymphocyte escape mutants.

Authors:  G F Rimmelzwaan; E G M Berkhoff; N J Nieuwkoop; D J Smith; R A M Fouchier; A D M E Osterhaus
Journal:  J Gen Virol       Date:  2005-06       Impact factor: 3.891

10.  Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.

Authors:  E G M Berkhoff; E de Wit; M M Geelhoed-Mieras; A C M Boon; J Symons; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more
  13 in total

1.  Immunogenicity of novel consensus-based DNA vaccines against avian influenza.

Authors:  Dominick J Laddy; Jian Yan; Natasha Corbitt; Gary P Kobinger; David B Weiner
Journal:  Vaccine       Date:  2007-01-30       Impact factor: 3.641

2.  H1N1pdm09 Influenza Virus and Its Descendants Lack Extra-epitopic Amino Acid Residues Associated With Reduced Recognition by M158-66-Specific CD8+ T Cells.

Authors:  Carolien E van de Sandt; Kyung A Sagong; Mark R Pronk; Theo M Bestebroer; Monique I Spronken; Marion P G Koopmans; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Infect Dis       Date:  2018-07-13       Impact factor: 5.226

3.  T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope.

Authors:  Angela Wahl; William McCoy; Fredda Schafer; Wilfried Bardet; Rico Buchli; Daved H Fremont; William H Hildebrand
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

4.  Immunodominant responses to the influenza virus M158-66 epitope: Stealth or protection?

Authors:  Carolien E van de Sandt; Guus F Rimmelzwaan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

5.  Detection of site-specific positive Darwinian selection on pandemic influenza A/H1N1 virus genome: integrative approaches.

Authors:  Ramaiah Arunachalam
Journal:  Genetica       Date:  2013-03-26       Impact factor: 1.082

6.  Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.

Authors:  Arwen F Altenburg; Carolien E van de Sandt; Stella E van Trierum; Heidi L M De Gruyter; Peter R W A van Run; Ron A M Fouchier; Kenny Roose; Xavier Saelens; Asisa Volz; Gerd Sutter; Rory D de Vries; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

7.  Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M158-66 Epitope-Specific CD8+ T Lymphocytes.

Authors:  Carolien E van de Sandt; Mark R Pronk; Carel A van Baalen; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

8.  The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro.

Authors:  E G M Berkhoff; M M Geelhoed-Mieras; E J Verschuren; C A van Baalen; R A Gruters; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Clin Exp Immunol       Date:  2007-02-26       Impact factor: 4.330

9.  Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design.

Authors:  Andy Ka-Leung Ng; Hongmin Zhang; Kemin Tan; Zongli Li; Jin-huan Liu; Paul Kay-Sheung Chan; Sui-Mui Li; Wood-Yee Chan; Shannon Wing-Ngor Au; Andrzej Joachimiak; Thomas Walz; Jia-Huai Wang; Pang-Chui Shaw
Journal:  FASEB J       Date:  2008-07-09       Impact factor: 5.191

10.  HLA class I molecules consistently present internal influenza epitopes.

Authors:  Angela Wahl; Fredda Schafer; Wilfried Bardet; Rico Buchli; Gillian M Air; William H Hildebrand
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.